Brought to you by:
Terumo Neuro receives FDA approval for carotid stent system
Terumo Neuro has announced that its carotid stent system has received premarket approval (PMA) from the Food and Drug Administration (FDA). This milestone marks the first dual-layer micromesh carotid stent approved in the U.S., offering physicians a clinically proven option…
VenoValve: Analysis finds similar improvement among both primary and thrombotic deep venous reflux patients
A new subanalysis of the SAVVE (Surgical antireflux venous valve endoprosthesis) trial found that there was no difference in the level of improvement in clinical outcomes and quality-of-life measures between patients who have either primary or thrombotic deep venous reflux.…
Cagent Vascular initiates patient enrollment in Serranator vs. plain balloon angioplasty OCT study
Cagent Vascular has announced its first patient enrolment in the Serranator versus plain balloon angioplasty optical coherence tomography (OCT) study. This prospective, randomized (2:1 treatment to control) dual-center study will enroll up to 60 patients. The study will utilize intravascular…
SCVS 2025: Rowe becomes SCVS president
Vincent Rowe, MD, from the University of California, Los Angeles (UCLA), became the 2025–26 Society for Clinical Vascular Surgery (SCVS) president during the Society’s 52nd Annual Symposium in Austin, Texas (March 29–April 2). Falling in line behind him are Peter…
SVS, medical organizations launch comprehensive Wound Care Curriculum
The Society for Vascular Surgery (SVS), in collaboration with the Society for Vascular Nursing (SVN) and the American Podiatric Medical Association (APMA), has designed an interprofessional curriculum to meet the needs of vascular wound care teams. As the collaborating organizations…
Novel phenotypic AAA classification may help better stratify aneurysm risk
Inspection of aortic lumen, wall and thrombus volume changes throughout the cardiac cycle enables novel classification of abdominal aortic aneurysms (AAAs) into four types “representing the complex wall-lumen-thrombus interaction,” a new study delivered during the 2025 Critical Issues America (CIA)…
Surmodics announces commercial release of Pounce XL thrombectomy system
Surmodics has announced the commercial release of the Pounce XL thrombectomy system for endovascular removal of acute or chronic clot from peripheral arteries. Intended for removal of thrombi and emboli from peripheral arteries ranging from 5.5–10mm in diameter, sizes typical of…
Gore announces FDA approval and first commercial implant of large-diameter thoracic tapers
Gore recently announced the expansion of the Gore Tag conformable thoracic stent graft with Active Control system product line, following Food and Drug Administration (FDA) approval of four new large-diameter tapered designs: 34x28mm, 37x31mm, 40x34mm and 45x37mm. News of the…
SCVS 2025: TBE device provides ‘safer’ option than TEVAR for blunt thoracic injuries in setting of zone 2 coverage
Use of the Gore Tag thoracic branch endoprosthesis (TBE) “offers a safer alternative” to traditional thoracic endovascular aortic repair (TEVAR) with left subclavian artery (LSA) coverage in blunt thoracic aortic injury (BTAI) requiring zone 2 coverage for zone 2 or…
ACC.25: Semaglutide improves walk distance for PAD patients with diabetes
Semaglutide significantly improved maximal walking distance in people with symptomatic peripheral arterial disease (PAD) and type 2 diabetes in a trial designed to evaluate the use of a GLP-1 agonist to manage PAD. In addition to improvements in walking ability…